Form4insider filings, from the source

SEC Form 4 · accession 0000921895-18-000046

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Jan 1, 2018
Accepted (ET)
Jan 3, 2018 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 1, 2018M9,985—A37,051D
Common StockF2,F3holding———83,308IBy: Separately Managed Account
Common StockF2,F4holding———13,910IBy: Lone Star Value Co-Invest I, LP
Common StockF2,F5holding———2,972,592IBy: Lone Star Value Investors, LP
9.00% Series A Cumulative Preferred StockF2,F5holding———383,985IBy: Lone Star Value Investors, LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF1—Jan 1, 2018M9,985D——Common Stock9,9850D

Explanation of responses